Mirna Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel microRNA-based therapeutics for the treatment of cancer. The company's proprietary platform technologies enable the design and development of highly specific and potent microRNA mimics and inhibitors to target multiple pathways involved in oncogenesis.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

9 Patents

#322 in Austin, TX

#2,059 in Texas

#32,588 in US

Austin, TX, United States of America

Mirna Therapeutics, Inc.

Forward Citations = 103

11 inventors:

David Allen Brown (8 out of 74 patents)

Kevin Kelnar (7 out of 20 patents)

Andreas Bader (3 out of 4 patents)

4. Jeffrey Shelton (2 out of 10 patents)

5. Jikui Shen (2 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Mirna Therapeutics, Inc.. Retrieved from https://idiyas.com/company/mirna-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]